Testing a polygenic risk score for morphological microglial activation in Alzheimer’s disease and aging is a research paper published in medRxiv (2023). On theSindex it has a DataRank of 0.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Canadian Institutes of Health Research
Grant: unidentified
unidentified
National Institutes of Health
Grant: 1U01AG024904-01
Alzheimers Disease Neuroimaging Initiative
National Institutes of Health
Grant: 3U01AG061356-02S1
Multi-omic network-directed proteoform discovery, dissection and functional validation to prioritize novel AD therapeutic targets
National Institutes of Health
Grant: 5R01AG017917-20
Epidemiologic Study of Neural Reserve and Neurobiology of Aging
National Institutes of Health
Grant: 1P30AG010161-01
SHORT-TERM STABILITY OF CLINICAL TESTS
National Institutes of Health
Grant: 7U01AG046152-05
Pathway discovery, validation and compound identification for Alzheimer's disease
National Institutes of Health
Grant: 5P30AG072975-02
Rush Alzheimer's Disease Research Center
National Institutes of Health
Grant: 5R01AG015819-07
Risk Factors, Pathology, and Clinical Expressions of AD
Fields of Study
Keywords
Sustainable Development Goals